What is the role of autologous vaccine therapy in the treatment of renal cell carcinoma (RCC)?

Updated: May 20, 2019
  • Author: Kush Sachdeva, MD; Chief Editor: E Jason Abel, MD  more...
  • Print
Answer

Autologous vaccine therapy is now being tried in combination with cytokine therapy. A pilot study of vaccinating with the corresponding mutant von Hippel-Lindau peptides demonstrated safety and proved efficacy in generating a specific immune response in patients with advanced renal cell carcinoma. [70]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!